Hypoglycemia is a frequent manifestation of glycogen storage diseases. As such, pediatric endocrinologists are often aid in the diagnosis and/or treatment of these diseases. To this end, Dr. Larson Ode has been assisting a new team of scientists who are working to better understand how to manage glycogen storage diseases. In a new scientific article, this group has characterized the genetic, metabolic, and lipidomic profiles of cultured fibroblasts from nine different persons affected by glycogen storage disease type III. These now well-characterized cell lines will be a useful tool to test new therapeutic approaches. The work is published in the journal Molecular Genetics and Metabolism, and its abstract can be found on PubMed at this link.